Embolism Flashcards
Among women who died after live birth the leading causes of death are
Embolism and PIH
Types of embolisms
Venous thromboembolism
PE
VAE
Amniotic fluid embolism
What is the risk of VTE with pregnancy
5-10x the risk
What physiological adaptions is VTE caused by
Venous stasis
Hypercoagulability
Damage to vessel wall
Virchows triad
Risk factors for VTE
> 35 y.o Higher parity Obesity Prolonged immobilization Surgery during pregnancy aka CS Family or personal history Pre-eclampsia Pelvic trauma Hereditary thrombophilia protein C and S deficiency
Clinical signs of PE
Most common: tachypnea and sudden onset of dyspnea
Tachycardia, desaturation
Lab findings with a PE
Hypoxemia
Resp alkalosis
Normal chest x ray
EKG findings with a PE
RV strain
ST segment abnormality
T wave inversion
Supraventricular arrhythmias
Respiratory failure, pulmonary HTN for PE may result from
Respiratory failure occurs from the occlusion of the pulmonary vasculature (V/Q mismatch), and pulmonary edema due to increased hydrostatic forces and the disruption of normal capillary integrity
Pulmonary HTN results from direct vascular obstruction and results in RV overload
Invasive monitoring with a PE reveals
Normal to low PA occlusion pressures
Increased mean PAP
Increased CVP
Diagnostic tests used for pE
V/Q scans
MRA
Spiral CT
Pulm angio
Pulm angio is required in
Patients who have a negative V/Q scan but strong clinical suspicion of PE or in severe cases for confirmation of PE before thrombolysis
What is the radiation dose to the fetus with a combination of CXR, V/Q scan, pulm angio
0.5 rad
> 5 is significant for tetratogenesis
Supportive measures for PE/VTE
Improve Oxygenation and circulation, O2 administration and cardiorespiratory support with fluids inotropes and vasopressors
RA filling pressures should be maintained at a high level to maintain output from the failing RV
Specific therapy for VTE/PE
Anticoag (heparin, LMWH)
Thrombolysis
What thrombolytics can be used during pregnancy
Streptokinase or urokinase, and r-tpa
Urokinase is less antigenic and should have fewer side effects
Does not induce systemic fibrinolysis but is active when bound to thrombin so it is clot specific
R-TPA
Antepartum and intrapartum complications from thrombolysis includes
Maternal hemorrhage and placental abruption
Which is the therapy of choice between heparin and LMWH
Unfractionated heparin
Dosing with heparin
Iv bolus then an infusion for PTT 1.5 to 2x the upper level of control values for 10-14 days
Followed by subq injections 5k-10ku q8-12 hours throughout pregnancy
When is heparin d/c
Shortly before delivery and restarted with warfarin
When the INR is between 2-3
Controversial during pregnancy for thromboprophylaxis
LMWH
Greater antithrombotic activity (factor xa) than anticoagulant activity (anti factor IIa)
it does not affect the aPTT
LMWH
Why does the smaller structure of LMWH have advantages over heparin
Prolonged serum half life
Decreased daily dosing
Lower protein binding
Lower risk of bleeding, and platelet activation and thrombocytopenia
How can air be demonstrated during CS
By precordial doppler auscultation
Risk factors for VAE
Gradient of -5cm H2O between periphery and the heart would allow significant entry of air into venous circulation
Trendelenburg and exteriorizing the uterus during CS increases the gradient
Uterine exteriorization predisposes to VAE by
Increasing the hydrostatic gradient by raising the incisional are above the level of the heart
By enlargement of the uterine sinuses providing more exposure to air
What physiologic occurrence causes death from VAE is
Circ arrest from air entrapped in the RV outflow tract
5ml/kg of air lethal for air lock in RV or in pulmonary arterial circ
Can result in cardiogenic shock
VAE with PA vasoconstriction can result in
Acute cor pulmonale
Air on endothelial surfaces results in
Increased capillary permeability, platelet activation, and coagulopathy
Massive VAE presents as
Hypotension, hypoxemia, cardiac arrest
6 signs of air embolism
Decreased end tidal Chest pain Tachypnea, dyspnea Cyanosis/mottled skin Wheel mill murmur auscultated through steth Tachycardia and hypotension
Resuscitation steps for massive PE
- D/c nitrous and give 100% fio2
- Prevent further air entrapment flood surgical field, change position
- Support ventilation as needed
- Support circ
- Consider placement of central line to aspirate
- Expedite delivery
- Delayed emergence from GA consider neurodiagnostic imaging to r/o intracerebral air (arterial gas embolism) benefit from hyperbaric therapy within 5 hours
The leading cause of mortality during labor and first few PP hours
AFE
Maternal death with AFE occurs in one of three ways
- Sudden cardiac arrest
- DIC
- ARDS MOF
Causes of AFE
Tear in amnion or chorion
Opens uterine and endocervical veins
Pressure is high to force amniotic fluid into venous circulation
Risk factors for AFE
Advanced age Multiparity Tumultuous labor ROM Fetal death Trauma Uterine overdistension
Aminotic fluid components that are biochemical mediators causing major effects and anaphylactoid reaction and multi system involvement
Surfactant Endothelin Leukotrienes C4 D4 Thromboxane A2 Prostaglandins Arachidonic acid Thromboplastin Collagen tissue factor III Phospholipase A2 PF III
Suspension amniotic fluid components causing minor effects and mechanical obstruction
Lanugo hair Vernix caseosa Fetal squames Bile stained meconium Fetal gut mucin Trophoblasts
Intermediate phase of anaphylactoid reaction to AFE
Occurs when initially exposed Respiratory distress Cyanosis Hemodynamic instability Cerebral hypoperfusion with seizures, confusion, coma
Second phase of anaphylactoid reaction to afe
Coagulopathy and hemorrhage
First and only presentation of AFE possibly
Third phase of anaphylactoid reaction to AFE
Tissue injury is established
Die from lung or brain injury, MOF, or infection acquired during ICU
Clinical manifestations of afe
Nonspecific 1. Respiratory distress 2. Cyanosis 3. CV collapse 4. Coma 5. Hemorrhage Hemorrhage and fetal distress initial symptoms
Diagnosis of AFE
CXR maybe normal
EKG RV strain early on
ECHO - severe LV failure
Difficult to do specific testing d/t hemodynamic instability
Past diagnosis of AFE
Autopsy by finding fetal squamous cells in maternal pulm circulation
AFE treatment is supportive and directed towards
Oxygenation CO, SBP >90 Organ perfusion UO >25ml/hr Coag corrections Uterine toning
Pharmacologic management if afe
Crystalloids, pressors, inotropic support
Restrict fluids after first hypotensive episode resolved to prevent pulm edema and ARDS
Corticosteroids hydrocort 500mg qh/hr
Heparin is controversial
CPB and thromboembolectomy
T or F therapy for PE focuses on prevention of recurrent PEs
T
T or F AFE may occur at any time during L and D
T